Evidence map›Paper›PMID 29436517›Full record

ArticleJournal of the American Society of Nephrology : JASN2018

Endogenous IL-33 Contributes to Kidney Ischemia-Reperfusion Injury as an Alarmin.

Maroua Ferhat, Aurélie Robin, Sébastien Giraud, Sandra Sena, Jean-Michel Goujon, Guy Touchard, Thierry Hauet, Jean-Philippe Girard, Jean-Marc Gombert, André Herbelin and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. ST2 Signaling Regulates Innate Immune Responses in Kidney Injury.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Immunomodulatory Functions of Intercalated Cells in Kidney Autoimmunity.bioRxiv : the preprint server for biology · 2025
    Article
  9. Innate Lymphoid Cells Are the Rheostat of Immune Response in the Kidney.Journal of cellular and molecular medicine · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. IL-33, a neutrophil extracellular trap-related gene involved in the progression of diabetic kidney disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  15. ST2 + T-Regulatory Cells in Renal Inflammation and Fibrosis after Ischemic Kidney Injury.Journal of the American Society of Nephrology : JASN · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Dual Time-Dependent Effects of Interleukin-33 Administration on the Kidney Postmyocardial Infarction.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2024
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Maroua FerhatUnité Mixte de Recherche 1082, Institut National de la Santé et de la Recherche Médicale, Poitiers, France.
Aurélie RobinUnité Mixte de Recherche 1082, Institut National de la Santé et de la Recherche Médicale, Poitiers, France.
Sébastien GiraudUnité Mixte de Recherche 1082, Institut National de la Santé et de la Recherche Médicale, Poitiers, France.
Sandra SenaUnité Mixte de Recherche 1082, Institut National de la Santé et de la Recherche Médicale, Poitiers, France.
Jean-Michel GoujonUnité Mixte de Recherche 1082, Institut National de la Santé et de la Recherche Médicale, Poitiers, France.
Guy TouchardFaculté de Médecine et de Pharmacie, University of Poitiers, Poitiers, France.
Thierry HauetUnité Mixte de Recherche 1082, Institut National de la Santé et de la Recherche Médicale, Poitiers, France.
Jean-Philippe GirardInstitute of Pharmacology and Structural Biology, Toulouse, France.
Jean-Marc GombertUnité Mixte de Recherche 1082, Institut National de la Santé et de la Recherche Médicale, Poitiers, France.
André HerbelinUnité Mixte de Recherche 1082, Institut National de la Santé et de la Recherche Médicale, Poitiers, France; andre.herbelin@inserm.fr.
Antoine ThierryUnité Mixte de Recherche 1082, Institut National de la Santé et de la Recherche Médicale, Poitiers, France.
Inserm · FRCentre Hospitalier Universitaire de Poitiers · FRUniversité de Poitiers · FRInstitut de Pharmacologie et de Biologie Structurale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is a prominent feature of ischemia-reperfusion injury (IRI), which is characterized by leukocyte infiltration and renal tubular injury. However, signals that initiate these events remain poorly understood. We examined the role of the nuclear alarmin IL-33 in tissue injury and innate immune response triggered by experimental kidney ischemia-reperfusion. In wild-type mice, we found that IL-33 was constitutively expressed throughout the kidney in peritubular and periglomerular spaces, mainly by microvascular endothelial cells, from which it was released immediately during IRI. Compared with wild-type mice, mice lacking IL-33 (IL-33

Indexed as

AlarminsAnimalsCytokinesDendritic CellsGene Expression RegulationImmunity, InnateInterferon-gammaInterleukin-12Interleukin-17Interleukin-1 Receptor-Like 1 ProteinInterleukin-33KidneyKiller Cells, NaturalMiceMice, Inbred C57BLMice, KnockoutAlarminsCytokinesIFNG protein, mouseIl17a protein, mouseIl1rl1 protein, mouseIl33 protein, mouseInterferon-gammaInterleukin-12Interleukin-17Interleukin-1 Receptor-Like 1 ProteinInterleukin-33cell activationcytokinesimmunologyischemia-reperfusion

Identifiers

PMID29436517
PMCPMC5875946
OpenAlexW2785644619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.